Future Science Group has announced the launch of a new journal - Future Drug Discovery. Led by an expert international Editorial Advisory Board, Future Drug Discovery is a peer-reviewed, open access journal covering the latest breakthrough science in drug discovery, research & development.
The field of drug discovery has historically been troubled by high failure rates, and multidisciplinary research and access to data are being increasingly embraced in order to improve success. The new journal will seek to harness these concepts, presenting new advances and discussing their applications and translation in an openly accessible format, and providing a forum for discussing the field at large.
The journal’s Editorial Advisory Board includes David Clark (Charles River Laboratories), Steve Rees (Astrazeneca), Johannes Reynisson (University of Auckland), Rob Williams and Neil Jones (Cancer Research UK), Edgar Jacoby (Janssen), Giulia Caron (University of Torino), Dave C Morris (University of North Carolina at Chapel Hill), Francis Wilson (Summit Therapeutics), Xingcai Zhang (Harvard University) and Jayanth Panyam (University of Minnesota).
Future Drug Discovery will be a quarterly publication publishing case histories, methodologies, original research, reviews and opinion articles covering the entire drug discovery pipeline, plus topics of interest to the drug discovery community. A comprehensive list of topics can be found at the journal webpage.
The journal’s latest content, which includes a forward-looking perspective on publishing in drug discovery, an editorial on open science in rare diseases research, and a research article examining experimental lipophilicity for beyond Rule of 5 compounds, is available ahead of print.
The editorial office is now actively soliciting contributions of original research, reviews and opinion pieces for the journal.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
